EMA recommended 8⃣9⃣ human #medicines for marketing authorisation in 2022.

4⃣1⃣ had a new active substance which had never been authorised in the 🇪🇺 before.

Consult our annual human medicines highlights: https://ema.europa.eu/en/news/human-medicines-highlights-2022

#PublicHealth #HealthUnion

🐦🔗: https://n.respublicae.eu/EMA_News/status/1626255686995742734